HUP0203676A3 - Pharmaceutical composition and method for treatment of diabetes - Google Patents

Pharmaceutical composition and method for treatment of diabetes

Info

Publication number
HUP0203676A3
HUP0203676A3 HU0203676A HUP0203676A HUP0203676A3 HU P0203676 A3 HUP0203676 A3 HU P0203676A3 HU 0203676 A HU0203676 A HU 0203676A HU P0203676 A HUP0203676 A HU P0203676A HU P0203676 A3 HUP0203676 A3 HU P0203676A3
Authority
HU
Hungary
Prior art keywords
diabetes
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
HU0203676A
Other languages
English (en)
Hungarian (hu)
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Publication of HUP0203676A2 publication Critical patent/HUP0203676A2/hu
Publication of HUP0203676A3 publication Critical patent/HUP0203676A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0203676A 2000-01-27 2001-01-29 Pharmaceutical composition and method for treatment of diabetes HUP0203676A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000258A SE0000258D0 (sv) 2000-01-27 2000-01-27 Pharmaceutical preparation and method for treatment of diabetes
PCT/SE2001/000169 WO2001054700A1 (en) 2000-01-27 2001-01-29 Pharmaceutical preparation and method for treatment of diabetes

Publications (2)

Publication Number Publication Date
HUP0203676A2 HUP0203676A2 (hu) 2003-04-28
HUP0203676A3 true HUP0203676A3 (en) 2003-08-28

Family

ID=20278246

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203676A HUP0203676A3 (en) 2000-01-27 2001-01-29 Pharmaceutical composition and method for treatment of diabetes

Country Status (18)

Country Link
US (1) US6908904B2 (pt)
EP (1) EP1320372B1 (pt)
JP (1) JP2003520818A (pt)
KR (1) KR20030005168A (pt)
CN (1) CN1396831A (pt)
AT (1) ATE310525T1 (pt)
AU (1) AU778994B2 (pt)
BR (1) BR0107871A (pt)
CA (1) CA2398206A1 (pt)
CZ (1) CZ20022519A3 (pt)
DE (1) DE60115263D1 (pt)
HU (1) HUP0203676A3 (pt)
MX (1) MXPA02007196A (pt)
PL (1) PL356778A1 (pt)
RU (1) RU2266123C2 (pt)
SE (1) SE0000258D0 (pt)
SK (1) SK10762002A3 (pt)
WO (1) WO2001054700A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000258D0 (sv) 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides
EP2889039B1 (en) * 2012-08-22 2017-11-08 Regimmune Corporation Preparation for preventing or treating type i diabetes
WO2019238841A1 (en) * 2018-06-15 2019-12-19 Københavns Universitet Coating medical devices to avoid fibroblast overgrowth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
US5302609A (en) * 1992-12-16 1994-04-12 The Regents Of The University Of Michigan Treatment of diabetic nephropathy
SE9601817D0 (sv) * 1996-05-13 1996-05-13 Karsten Buschard Novel glycolipid complexex and their uses
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
KR100527950B1 (ko) * 1997-04-10 2005-11-09 기린 비루 가부시키가이샤 알파-글리코실세라미드를 함유하는 엔케이티 세포활성화제
AU750141B2 (en) * 1997-12-30 2002-07-11 A+ Science Invest Ab Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
SE0000258D0 (sv) 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes

Also Published As

Publication number Publication date
AU3069101A (en) 2001-08-07
CZ20022519A3 (cs) 2003-06-18
RU2266123C2 (ru) 2005-12-20
DE60115263D1 (de) 2005-12-29
WO2001054700A1 (en) 2001-08-02
EP1320372A1 (en) 2003-06-25
BR0107871A (pt) 2002-11-05
CA2398206A1 (en) 2001-08-02
PL356778A1 (en) 2004-07-12
US20030004115A1 (en) 2003-01-02
KR20030005168A (ko) 2003-01-17
HUP0203676A2 (hu) 2003-04-28
EP1320372B1 (en) 2005-11-23
JP2003520818A (ja) 2003-07-08
SE0000258D0 (sv) 2000-01-27
RU2002122982A (ru) 2004-03-20
SK10762002A3 (sk) 2003-07-01
ATE310525T1 (de) 2005-12-15
CN1396831A (zh) 2003-02-12
AU778994B2 (en) 2004-12-23
MXPA02007196A (es) 2003-01-28
US6908904B2 (en) 2005-06-21

Similar Documents

Publication Publication Date Title
AUPR638101A0 (en) Composition and method for treatment of disease
AU8657601A (en) Composition and method for treatment of hypertriglyceridemia
HK1048949A1 (en) Method and composition for the treatment of scars
AU2002329022A1 (en) Method and pharmaceutical composition for treating inflammation
AU6886201A (en) Composition for pain mediation and apparatus and method of use thereof
HK1066459A1 (en) Pharmaceutical dosage form and method of making
EP1363761A4 (en) TREATMENT MATERIAL AND TREATMENT METHOD FOR WOOD DEBITED
IL161073A0 (en) Composition and method for treating diabetes
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
EP1425027A4 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF WOUNDS AND BURNS
HUP0203676A3 (en) Pharmaceutical composition and method for treatment of diabetes
GB2399500B (en) Composition and method for treatment of wounds
AU2420101A (en) Method and composition for the treatment of pain
EP1423118A4 (en) METHOD AND COMPOSITION FOR CANCER TREATMENT
IL150202A0 (en) Method and composition for the treatment of pain
IL129180A0 (en) Method and pharmaceutical composition for wound healing
EP1408757A4 (en) METHOD AND COMPOSITION FOR EXTENDING DRUG STAY TIME IN INTESTINE
GB0001647D0 (en) Novel composition and method for the treatment of drug abuse
GB0001390D0 (en) Composition and method for the treatment of drug abuse
HUP0700127A3 (en) Pharmaceutical combinations for treatment and of diabetes mellitus
GB9928681D0 (en) Method and composition for treatment or prophylaxis of diabetes
GB9915539D0 (en) Composition and method for the treatment of drug abuse
GB9926218D0 (en) Composition and method for the treatment of drug abuse
GB9930342D0 (en) Improved composition and method for the treatment of drug abuse
GB9922405D0 (en) New composition and method for the treatment of drug abuse